Jun 2026 (Q2 FY26) — Jul 29, 2026
Renasant Q2 FY26 — Strong Adjusted Earnings and Core Deposit Growth
Read the full callRenasant earnings: last reported Wed, 29 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 87.1 | +8455.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
14 of 14 judged targets kept · 8 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Core noninterest expense (NIE) quarterly outlook | low single-digit percent increase in NIE from Q1 FY26 | Mar 2026 | Noninterest expense was $161.5 million for the second quarter, a linked quarter increase of $6.2 million, mostly driven by deferred compensation accruals tied to market valuations, higher health insurance claims and annual merit increases. | Achieved |
| CET1 capital ratio target | accrete capital roughly 60 to 80 basis points a year | Mar 2025 | we'd like CET1 to be in the low 11s. And I don't think that will change. | On Track |
8 of RENASANT CORP's 22 targets are still open. See which are on track and which have gone quiet. The 2 above are the free sample; 20 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $36.58 on 14 Oct 2025 → $39.77. High $44.3 (4 Aug 2026), low $33.4 (17 Nov 2025).
Overview
Guidance
14 of 14 judged targets kept · 8 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Core noninterest expense (NIE) quarterly outlook | low single-digit percent increase in NIE from Q1 FY26 | Mar 2026 | Noninterest expense was $161.5 million for the second quarter, a linked quarter increase of $6.2 million, mostly driven by deferred compensation accruals tied to market valuations, higher health insurance claims and annual merit increases. | Achieved |
| CET1 capital ratio target | accrete capital roughly 60 to 80 basis points a year | Mar 2025 | we'd like CET1 to be in the low 11s. And I don't think that will change. | On Track |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 22 tracked commitments, with each call’s wording and source.
Call summaries
Renasant Q2 FY26 — Strong Adjusted Earnings and Core Deposit Growth
Read the full callRenasant Corporation Q1 FY26 — Strong Profitability and Efficiency Gains
Read the full callEvery analysed call
Financials
Net profit, year on year: +8455% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Profit before tax | 97 | 50 | 52 | 3 | 75 | 97 | 110 | 109 |
| Tax rate | 25.6% | 10.1% | 20.1% | 61.8% | 20.6% | 18.5% | 20.1% | 19.8% |
| Net profit | 72 | 45 | 42 | 1 | 60 | 79 | 88 | 87 |
| EPS ($ per share) | 1.18 | — | 0.65 | 0.01 | 0.63 | — | 0.94 | 0.95 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 296 | 296 | 296 | 296 | 296 | 296 | 332 | 489 |
| Reserves | 501 | 617 | 616 | 742 | 858 | 952 | 1,094 | 1,197 |
| Total liabilities | 10,891 | 11,275 | 12,797 | 14,600 | 14,852 | 15,063 | 15,357 | 22,867 |
| Fixed assets | 209 | 310 | 300 | 293 | 284 | 283 | — | — |
| Total assets | 12,935 | 13,401 | 14,930 | 16,810 | 16,988 | 17,361 | 18,035 | 26,751 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 82 | 164 | 82 | 143 | 574 | 149 | 106 | 271 |
| Cash from investing | -503 | -506 | -1,266 | -660 | -2,044 | -55 | -275 | -734 |
| Cash from financing | 709 | 188 | 1,402 | 1,762 | 168 | 132 | 459 | 441 |
| Net cash flow | 288 | -154 | 218 | 1,245 | -1,302 | 225 | 291 | -21 |
| Capital expenditure | -22 | -35 | -28 | -21 | -15 | -22 | -14 | -34 |
| Free cash flow | 60 | 129 | 54 | 122 | 559 | 127 | 93 | 238 |
60 filings between Nov 11, 2025 and Oct 5, 2026.
Purchases
$69.6K
1 purchase by 1 insider
Sales
$3.72M
10 sales by 8 insiders
Also filed: 7 dispositions to the issuer, 2 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| MCGRAW EDWARD ROBINSON | — | $1.54M | Aug 3, 2026 |
| COLE M RAY JR | — | $812.5K | Feb 13, 2026 |
| WAYCASTER C MITCHELL | — | $501.8K | May 14, 2026 |
| Mabry James C. IV | — | $472.9K | Jan 30, 2026 |
| Jeanfreau Mark | — | $227.3K | Feb 2, 2026 |
| LEVY JONATHAN A | $69.6K | — | Nov 11, 2025 |
| DALE ALBERT J III | — | $65.7K | May 19, 2026 |
| Hutcheson Kelly | — | $52.2K | Mar 4, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | MEALOR CATHERINE EVP | Award | 11,273 | $0 |
| Aug 3, 2026 | MCGRAW EDWARD ROBINSON Director | Sale | 35,000 | $1.54M |
| May 29, 2026 | Engel Connie L Director | Sale | 1,257 | $51.4K |
| May 19, 2026 | DALE ALBERT J III Director | Sale | 1,650 | $65.7K |
| May 15, 2026 | MCGRAW EDWARD ROBINSON Director | Option exercise | 1,040 | $41.4K |
| May 15, 2026 | MCGRAW EDWARD ROBINSON Director | Tax withheld | 385 | $15.3K |
| May 14, 2026 | WAYCASTER C MITCHELL Executive Vice Chairman | Sale | 12,704 | $501.8K |
| Apr 28, 2026 | Clark Donald JR Director | Award | 2,060 | $0 |
| Apr 28, 2026 | Deer Jill V Director | Award | 2,060 | $0 |
| Apr 28, 2026 | HOLLAND NEAL A JR Director | Award | 2,060 | $0 |
| Apr 28, 2026 | CREEKMORE JOHN Director | Award | 2,060 | $0 |
| Apr 28, 2026 | FOY JOHN Director | Award | 2,060 | $0 |
| Apr 28, 2026 | MCGRAW EDWARD ROBINSON Director | Award | 2,060 | $0 |
| Apr 28, 2026 | Engel Connie L Director | Award | 2,060 | $0 |
| Apr 28, 2026 | Butler Gary D. Director | Award | 2,060 | $0 |
| Apr 28, 2026 | Suggs Sean M. Director | Award | 2,060 | $0 |
| Apr 28, 2026 | Flenorl Rose J. Director | Award | 2,060 | $0 |
| Apr 28, 2026 | Moore Diana Renee Director | Award | 2,060 | $0 |
| Apr 28, 2026 | DALE ALBERT J III Director | Award | 2,060 | $0 |
| Apr 28, 2026 | PARKER TED E Director | Award | 2,060 | $0 |
| Apr 28, 2026 | LEVY JONATHAN A Director | Award | 2,060 | $0 |
| Apr 1, 2026 | COLE M RAY JR SEVP and Executive Advisor | Award | 14,531 | $0 |
| Mar 19, 2026 | Meredith David Executive Vice President | Disposition to issuer | 1,697 | $0 |
| Mar 19, 2026 | Chapman Kevin D President and CEO | Tax withheld | 7,372 | $253.5K |
| Mar 19, 2026 | Chapman Kevin D President and CEO | Disposition to issuer | 3,816 | $0 |
| Mar 19, 2026 | COCHRAN JAMES SCOTT Executive Vice President | Tax withheld | 3,986 | $137.1K |
| Mar 19, 2026 | WAYCASTER C MITCHELL Executive Vice Chairman | Tax withheld | 10,858 | $373.4K |
| Mar 19, 2026 | COCHRAN JAMES SCOTT Executive Vice President | Disposition to issuer | 2,279 | $0 |
| Mar 19, 2026 | WAYCASTER C MITCHELL Executive Vice Chairman | Disposition to issuer | 5,854 | $0 |
| Mar 19, 2026 | Meredith David Executive Vice President | Tax withheld | 3,001 | $103.2K |
| Mar 19, 2026 | Perry Curtis J EVP | Tax withheld | 4,296 | $147.7K |
| Mar 19, 2026 | Jeanfreau Mark EVP/General Counsel | Disposition to issuer | 1,697 | $0 |
| Mar 19, 2026 | Mabry James C. IV EVP and CFO | Tax withheld | 5,272 | $181.3K |
| Mar 19, 2026 | Mabry James C. IV EVP and CFO | Disposition to issuer | 2,279 | $0 |
| Mar 19, 2026 | Jeanfreau Mark EVP/General Counsel | Tax withheld | 3,302 | $113.6K |
| Mar 19, 2026 | Perry Curtis J EVP | Disposition to issuer | 2,279 | $0 |
| Mar 4, 2026 | Hutcheson Kelly EVP/Chief Accounting Officer | Sale | 1,350 | $52.2K |
| Feb 13, 2026 | COLE M RAY JR SEVP and Executive Advisor | Sale | 1,162 | $47.2K |
| Feb 13, 2026 | COLE M RAY JR SEVP and Executive Advisor | Sale | 17,778 | $722.2K |
| Feb 13, 2026 | COLE M RAY JR SEVP and Executive Advisor | Sale | 1,060 | $43.1K |
| Feb 2, 2026 | Jeanfreau Mark EVP/General Counsel | Sale | 6,000 | $227.3K |
| Jan 30, 2026 | Mabry James C. IV EVP and CFO | Sale | 12,500 | $472.9K |
| Jan 27, 2026 | Hutcheson Kelly EVP/Chief Accounting Officer | Award | 3,078 | $0 |
| Jan 27, 2026 | WAYCASTER C MITCHELL Executive Vice Chairman | Award | 4,561 | $0 |
| Jan 23, 2026 | Hutcheson Kelly EVP/Chief Accounting Officer | Tax withheld | 876 | $30.9K |
| Jan 1, 2026 | Chapman Kevin D President and CEO | Award | 24,018 | $0 |
| Jan 1, 2026 | Chapman Kevin D President and CEO | Award | 24,018 | $0 |
| Jan 1, 2026 | Perry Curtis J EVP | Award | 6,587 | $0 |
| Jan 1, 2026 | Perry Curtis J EVP | Award | 6,587 | $0 |
| Jan 1, 2026 | COCHRAN JAMES SCOTT Executive Vice President | Award | 5,764 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow RENASANT CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading